Fundraising Fox
Genomadix
2 known investors
Find your way into Genomadix
Sign up to see every warm intro you have to Genomadix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genomadix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.
Investors · 2
Also in the syndicate · 1
ICW Ventureslead
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundJul 2022
ICW Ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Genomadix do?
- Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.
- Who are Genomadix's investors?
- Genomadix's investors include UCeed Funds.